Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

Clinical trial NCT00064584 · COMPLETED

Trial details

NCT number: NCT00064584
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Myelodysplastic Syndrome

Start date: 2002-05-01
Primary completion: 2005-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.